{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:50:08Z","timestamp":1789012208791,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.brachy.2024.09.005","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:35:04Z","timestamp":1734611704000},"page":"92-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of chemotherapy combined with iodine-125 seed brachytherapy for intermediate and advanced oncogenic driver gene-negative non-small cell lung cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9298-6232","authenticated-orcid":false,"given":"Meng-hua","family":"xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-cai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-zhuang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-qin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Fu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.09.005_bib0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends: an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.brachy.2024.09.005_bib0002","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2024.09.005_bib0003","doi-asserted-by":"crossref","first-page":"506","DOI":"10.21037\/tlcr.2020.03.40","article-title":"Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival","volume":"10","author":"Casal-Mouri\u00f1o","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.brachy.2024.09.005_bib0004","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1158\/1078-0432.CCR-16-1673","article-title":"Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade","volume":"23","author":"Dovedi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.brachy.2024.09.005_bib0005","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.09.005_bib0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1259\/bjr.74.877.740056","article-title":"A purpose-built iodine-125 irradiation plaque for low dose rate low energy irradiation of cell lines in vitro","volume":"74","author":"Aird","year":"2001","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2024.09.005_bib0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.lungcan.2007.12.016","article-title":"CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC)","volume":"61","author":"Mart\u00ednez-Monge","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.brachy.2024.09.005_bib0008","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.canrad.2014.06.009","article-title":"Radioth\u00e9rapie conformationnelle avec modulation d'intensit\u00e9 dans les carcinomes bronchiques non \u00e0 petites cellules [Intensity-modulated radiation therapy in non-small cell lung cancers]","volume":"18","author":"Ayadi","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2024.09.005_bib0009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2014.06.008","article-title":"Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patients","volume":"14","author":"Yorozu","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.09.005_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4161\/cbt.8.7.7902","article-title":"Short- to mid-term evaluation of CT-guided 125I brachytherapy on intra-hepatic recurrent tumors and\/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.brachy.2024.09.005_bib0011","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2147\/OTT.S129903","article-title":"125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy: a comparison with best supportive care","volume":"10","author":"Song","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.brachy.2024.09.005_bib0012","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-2007-995476","article-title":"Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study","volume":"40","author":"Jin","year":"2008","journal-title":"Endoscopy"},{"key":"10.1016\/j.brachy.2024.09.005_bib0013","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4161\/cbt.20834","article-title":"Recurrent gliomas: comparison of computed tomography (CT)-guided 125I seed implantation therapy and traditional radiochemotherapy","volume":"13","author":"Hu","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.brachy.2024.09.005_bib0014","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.ijrobp.2009.03.049","article-title":"Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy","volume":"76","author":"Hinnen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.09.005_bib0015","doi-asserted-by":"crossref","first-page":"E411","DOI":"10.5489\/cuaj.478","article-title":"Evidencebased guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer","volume":"7","author":"Rodrigues","year":"2013","journal-title":"Can Urol Assoc J 1\u20444 Journal De L'Association Des Urologues Du Canada"},{"key":"10.1016\/j.brachy.2024.09.005_bib0016","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/hed.25813","article-title":"Efficacy of combined surgery and (125) I seed brachytherapy for treatment of primary mucoepidermoid carcinoma of the parotid gland","volume":"41","author":"Wu","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.brachy.2024.09.005_bib0017","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/1759-7714.12912","article-title":"Chinese Expert Consensus Workshop Report: guideline for permanent iodine-125 seed implantation of primary and metastatic lung tumors","volume":"10","author":"Zhang","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.brachy.2024.09.005_bib0018","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4103\/jcrt.JCRT_96_18","article-title":"Chinese expert consensus on radioactive 125I seeds interstitial implantation brachytherapy for pancreatic cancer","volume":"14","author":"Gai","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.brachy.2024.09.005_bib0019","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the tnm stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.brachy.2024.09.005_bib0020","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.diii.2014.05.002","article-title":"Imaging criteria for assessing tumour response: RECIST, mRECIST, Cheson","volume":"95","author":"Fournier","year":"2014","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.brachy.2024.09.005_bib0021","unstructured":"U.S. Department of Health and Human Services NIH, National Cancer Institute. Common Terminology Criteriafor Adverse Events (CTCAE) Version 4.0. http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06."},{"key":"10.1016\/j.brachy.2024.09.005_bib0022","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13014-023-02372-8","article-title":"Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes","volume":"18","author":"Jin","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.09.005_bib0023","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jtho.2022.07.1148","article-title":"Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC: the phase 2 PACIFIC-6 trial","volume":"17","author":"Garassino","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.brachy.2024.09.005_bib0024","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.canrad.2014.06.009","article-title":"[Intensity-modulated radiation therapy in non-small cell lung cancers]","volume":"18","author":"Ayadi","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2024.09.005_bib0025","first-page":"5969","article-title":"Iodine-125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non-small cell lung cancer A549 \u00d7enografts","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.brachy.2024.09.005_bib0026","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/1574892809666140331151747","article-title":"Cell-based assay system to estimate the effect of 125I seeds on cancer cells: effect of osteopontin","volume":"9","author":"Yang","year":"2014","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.brachy.2024.09.005_bib0027","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/OTT.S18155","article-title":"Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC","volume":"4","author":"Ballas","year":"2011","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.brachy.2024.09.005_bib0028","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00432-011-1048-3","article-title":"The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer","volume":"137","author":"Zhang","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.brachy.2024.09.005_bib0029","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.2147\/OTT.S174457","article-title":"Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly","volume":"11","author":"Wu","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.brachy.2024.09.005_bib0030","first-page":"957","article-title":"Meta-analysis of the efficacy and safety of intertissue implantation of \u223c(125)I seed for lung cancer","volume":"15","author":"Linmiao","year":"2015","journal-title":"Chin J Evidence-Based Med"},{"key":"10.1016\/j.brachy.2024.09.005_bib0031","first-page":"592","article-title":"Efficacy of 125I seed implantation combined with intravenous chemotherapy in treatment of stage IIIb and non-small cell lung cancer","volume":"14","author":"Chu","year":"2017","journal-title":"Chin J Interv Imaging Ther"},{"key":"10.1016\/j.brachy.2024.09.005_bib0032","doi-asserted-by":"crossref","first-page":"e2249","DOI":"10.1097\/MD.0000000000002249","article-title":"125I brachytherapy in locally advanced nonsmall cell lung cancer after progression of concurrent radiochemotherapy","volume":"94","author":"Xiang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.brachy.2024.09.005_bib0033","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00432-014-1655-x","article-title":"CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy","volume":"140","author":"Zhang","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.brachy.2024.09.005_bib0034","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.2147\/OTT.S174457","article-title":"Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly","volume":"11","author":"Wu","year":"2018","journal-title":"Onco Targets Ther"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124003982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124003982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T23:31:59Z","timestamp":1740612719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124003982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1538472124003982"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.09.005","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of chemotherapy combined with iodine-125 seed brachytherapy for intermediate and advanced oncogenic driver gene-negative non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}